Accensi Pty Ltd v Nufarm Limited

Link copied
Case Copied 10 min read

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Accensi Pty Ltd v Nufarm Limited [2014] APO 57

Patent:2002325065

Title:Glyphosate composition

Patentee:  Nufarm Limited

Opponent:  Accensi Pty Ltd

Delegate:  Dr S.D. Barker

Decision Date:  5 August 2014

Hearing Date:  21 July 2014, in Canberra

Catchwords:  PATENTS – opposition under section 104 – whether alleged deficiencies arise as a result of the amendment – opposition fails

Representation:  Patent applicant:  Mr Ben Fitzpatrick of counsel, assisted by Mr Christopher Schlicht, patent attorney of Phillips Ormonde Fitzpatrick

Opponent:Mr Paul Whenman, patent attorney of FB Rice

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Patent Application:                   2002325065

Title:Glyphosate composition

Patent Applicant:  Nufarm Limited

Date of Decision:  5 August 2014

DECISION

The opposition fails.  Subject to appeal, the amendment is allowed.

I award costs according to Schedule 8 against Accensi Pty Ltd.

REASONS FOR DECISION

  1. Patent number 2002325065 was granted on 23 June 2011.  The patentee is Nufarm Limited (Nufarm).  A request to re-examine the patent was filed by Accensi Pty Ltd (Accensi) on 10 February 2012.  Amendments that were filed in response to the re-examination were advertised, and an opposition to the amendments was filed by Accensi.  A hearing was conducted in Canberra on 21 July 2014. 

    The opposition

  2. The statement of grounds and particulars identified two grounds of opposition:  lack of compliance with sections 102(1) and 102(2)(b).  Both grounds were argued at the hearing.

  3. The parties relied upon evidence by several declarants.  Evidence in support consists of a declaration by Mirsad Ahmetagic.  Evidence in answer consists of a declaration by Phillip Maxwell Hay.  Evidence in reply consists of a further declaration by Mirsad Ahmetagic. 

    The law on amendments

  4. The grounds for opposing an amendment are that the amendment is not allowable under section 102.  Changes to section 102 as a consequence of the commencement of the Intellectual Property Laws Amendment (Raising the Bar) Act 2011 do not apply to the present specification because the request for examination of the present application was made before 15 April 2013. 

  5. The relevant provisions of section 102 are as follows:

    (1) An amendment of a complete specification is not allowable if, as a result of the amendment, the specification would claim matter not in substance disclosed in the specification as filed.
    (2) An amendment of a complete specification is not allowable after the specification has been accepted if, as a result of the amendment:

    (a) a claim of the specification would not in substance fall within the scope of the claims of the specification before amendment; or
    (b) the specification would not comply with subsection 40(2) or (3).

  6. The key issue for the present matter is the expression "as a result of the amendment".  This was discussed by Yates J in Bristol-Myers Squibb Company v Apotex Pty Ltd [2010] FCA 814 at [38] in relation to section 102(1) (and the same applies to section 102(2)):

    "Consideration of the prohibition in s 102(1) of the Act requires a comparison between what would be claimed as a result of the proposed amendment and what is disclosed…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Accensi Pty Ltd v Nufarm Limited and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2014] APO 57
Decision Date

CaseChat Overview and Summary

The case of Accensi Pty Ltd v Nufarm Limited concerns an opposition to the proposed amendments of a patent application for a glyphosate composition, held by Nufarm Limited. Accensi Pty Ltd filed the opposition to the proposed amendments on the basis that they did not comply with sections 102(1) and 102(2)(b) of the relevant legislation. The primary legal issues for the court to decide were whether the alleged deficiencies in the amended claims and specification arose as a result of the amendment, and whether the amendment would claim matter not in substance disclosed in the specification as filed.

The court considered the evidence provided by the parties and examined the relevant provisions of section 102, particularly the expression "as a result of the amendment." The court held that the key issue was whether the alleged deficiencies arose as a result of the amendment, as per the case of Bristol-Myers Squibb Company v Apotex Pty Ltd. The court concluded that the deficiencies raised in the opposition did not arise as a result of the amendment.

In its decision, the court found that the opposition failed as the alleged deficiencies did not arise as a result of the amendment. The court held that the proposed amendments were allowable and awarded costs according to Schedule 8 against Accensi Pty Ltd. The court emphasised that it was not necessary to express an opinion on whether the features in question should be included in the specification.

The final orders of the court were that the opposition fails, the amendment is allowed subject to appeal, and costs are awarded against Accensi Pty Ltd.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established